复星医药：上半年归母净利润17.02亿元，同比增长38.96%

Core Insights - Fosun Pharma reported a revenue of 19.514 billion yuan for the first half of the year, representing a year-on-year decline of 4.63% [1] - The net profit attributable to shareholders of the listed company was 1.702 billion yuan, showing a year-on-year increase of 38.96% [1] - The basic earnings per share stood at 0.64 yuan [1]